Biotech

Hong Kong is quickly developing into one of the world’s leading innovation hubs, with healthtech and biotech at the forefront.

According to the 2024 Global Hepatitis Report by the World Health Organization, viral hepatitis is the second leading infectious cause of death globally – resulting in 1.3 million deaths per year and an average of 3,500 lives a day.

China’s 14th Five-Year Plan supports Hong Kong’s development into an international innovation and technology hub, which will provide new opportunities in healthcare and promote the city as an international health innovation hub.

The Hong Kong Polytechnic University has been at the forefront of addressing myopia, an eye disorder that affects one-third of the global population, with a novel non-invasive solution to control the development of myopia in children.

Two flagship events, the Asia Summit on Global Health and the Hong Kong International Medical and Healthcare Fair (Medical Fair), will be held next week, highlighting Hong Kong’s strengths in healthcare.

Positioned as Asia’s premier event on health innovation and investment, the Asia Summit on Global Health (ASGH), jointly organised by the Hong Kong SAR Government and the Hong Kong Trade Development Council (HKTDC), is a one-stop cross-disciplinary platform that will bring together all stakeholders.